02 Jul 2025 Avacta Provides Q2 2025 Business Update Outlining Progress Against Strategic Objectives Investors
01 Jul 2025 Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development Investors | Therapeutics